Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2018-02-24 00:50 CET (UTC+1h)
 

EMA Product Specific GL [Regulatives / Guidelines]

posted by mmw - India, 2017-07-14 14:50  - Posting: # 17548
Views: 2,305

Dear all,

EMA adopted a new batch of product specific guidances. Published on 10/07/2017:

Crizotinib
Elvitegravir / cobicistat / emtricitabine / te­no­fovir disoproxil
Elvitegravir
Emtricitabine, rilpivirine, tenofovir, disopro­xil
Vortioxetine

Thanks

MMW

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,939 Posts in 3,821 Threads, 1,122 registered users;
26 users online (0 registered, 26 guests).

In general, scientific progress calls for no more
than the absorption and elaboration of new ideas –
and this is a call most scientists are happy to heed.    Werner Heisenberg

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed